Protein kinase C (PKC)-mediated intracellular signaling participates in several key steps of hematopoietic cell differentiation. The ε isoform of PKC has been associated with erythroid differentiation as well as with the early phases of megakaryocytic (MK) lineage commitment. Here, we worked on the hypothesis that PKCε expression levels might be modulated during MK differentiation, with a specific role in the early as well as in the late phases of thrombopoiesis. We demonstrate that - at variance with the erythroid lineage development - PKCε is completely downmodulated in TPO-induced CD34 cells from day 6 onward. The forced expression of PKCε in the late phases of MK differentiation delays the phenotypic differentiation of progenitors likely via Bcl-xL upregulation. Moreover, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), known as a negative regulator of early erythroid expansion, is not apoptogenic for thrombopoietin-induced CD34 cells, but rather accelerates their maturation. However, PKCε levels negatively interfere also with the effects of TRAIL in MK differentiation. PKCε can therefore be considered a signaling intermediate whose expression levels are finely tuned, with a virtually opposite kinetic, in erythroid versus megakaryocytic lineages, to adequately respond to the signaling requirements of the specific hematopoietic lineage.

Timing and expression level of protein kinase Cε regulate the megakaryocytic differentiation of human CD34 cells / G. Gobbi, P. Mirandola, I. Sponzilli, C. Micheloni, C. Malinverno, L. Cocco, M. Vitale. - In: STEM CELLS. - ISSN 1066-5099. - 25:9(2007), pp. 2322-2329. [10.1634/stemcells.2006-0839]

Timing and expression level of protein kinase Cε regulate the megakaryocytic differentiation of human CD34 cells

C. Malinverno;
2007

Abstract

Protein kinase C (PKC)-mediated intracellular signaling participates in several key steps of hematopoietic cell differentiation. The ε isoform of PKC has been associated with erythroid differentiation as well as with the early phases of megakaryocytic (MK) lineage commitment. Here, we worked on the hypothesis that PKCε expression levels might be modulated during MK differentiation, with a specific role in the early as well as in the late phases of thrombopoiesis. We demonstrate that - at variance with the erythroid lineage development - PKCε is completely downmodulated in TPO-induced CD34 cells from day 6 onward. The forced expression of PKCε in the late phases of MK differentiation delays the phenotypic differentiation of progenitors likely via Bcl-xL upregulation. Moreover, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), known as a negative regulator of early erythroid expansion, is not apoptogenic for thrombopoietin-induced CD34 cells, but rather accelerates their maturation. However, PKCε levels negatively interfere also with the effects of TRAIL in MK differentiation. PKCε can therefore be considered a signaling intermediate whose expression levels are finely tuned, with a virtually opposite kinetic, in erythroid versus megakaryocytic lineages, to adequately respond to the signaling requirements of the specific hematopoietic lineage.
megakaryocytopoiesis; stem cells; cytokines; thrombopoietin; tumor necrosis factor-related apoptosis-inducing ligand
Settore MED/04 - Patologia Generale
2007
Article (author)
File in questo prodotto:
File Dimensione Formato  
Gobbi_et_al-2007-STEM_CELLS.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.2 MB
Formato Adobe PDF
1.2 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/564061
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 39
social impact